361 related articles for article (PubMed ID: 7871533)
1. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
Diliberto JJ; Akubue PI; Luebke RW; Birnbaum LS
Toxicol Appl Pharmacol; 1995 Feb; 130(2):197-208. PubMed ID: 7871533
[TBL] [Abstract][Full Text] [Related]
2. Relationship between CYP1A enzyme activities and protein levels in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
DeVito MJ; Beebe LE; Menache M; Birnbaum LS
J Toxicol Environ Health; 1996 Mar; 47(4):379-94. PubMed ID: 8600290
[TBL] [Abstract][Full Text] [Related]
3. Time- and concentration-dependent induction of CYP1A1 and CYP1A2 in precision-cut rat liver slices incubated in dynamic organ culture in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Drahushuk AT; McGarrigle BP; Slezak BP; Stegeman JJ; Olson JR
Toxicol Appl Pharmacol; 1999 Mar; 155(2):127-38. PubMed ID: 10053167
[TBL] [Abstract][Full Text] [Related]
4. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) distribution and cytochrome P4501A induction in young adult and senescent male mice.
Pegram RA; Diliberto JJ; Moore TC; Gao P; Birnbaum LS
Toxicol Lett; 1995 Mar; 76(2):119-26. PubMed ID: 7725343
[TBL] [Abstract][Full Text] [Related]
5. Rainbow trout hepatic mixed-function oxygenase induction by polychlorinated dibenzo-p-dioxins (PCDDs) as a function of time and tissue concentration.
Parrott JL; Hodson PV; Dixon DG
J Toxicol Environ Health; 1995 Nov; 46(3):301-16. PubMed ID: 7473859
[TBL] [Abstract][Full Text] [Related]
6. Induction of cytochrome P450 isoenzymes after toxicokinetic interactions between 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,2',4,4',5,5'-hexachlorobiphenyl in the liver of the mouse.
De Jongh J; DeVito M; Nieboer R; Birnbaum L; Van den Berg M
Fundam Appl Toxicol; 1995 May; 25(2):264-70. PubMed ID: 7665010
[TBL] [Abstract][Full Text] [Related]
7. Subchronic Exposure of [3H]- 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in female B6C3F1 mice: relationship of steady-state levels to disposition and metabolism.
Diliberto JJ; DeVito MJ; Ross DG; Birnbaum LS
Toxicol Sci; 2001 Jun; 61(2):241-55. PubMed ID: 11353133
[TBL] [Abstract][Full Text] [Related]
8. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
Tritscher AM; Goldstein JA; Portier CJ; McCoy Z; Clark GC; Lucier GW
Cancer Res; 1992 Jun; 52(12):3436-42. PubMed ID: 1596902
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection.
Abraham K; Krowke R; Neubert D
Arch Toxicol; 1988; 62(5):359-68. PubMed ID: 3242446
[TBL] [Abstract][Full Text] [Related]
11. Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and CYP1A2 related enzyme activities.
Vogel C; Donat S; Döhr O; Kremer J; Esser C; Roller M; Abel J
Arch Toxicol; 1997; 71(6):372-82. PubMed ID: 9195019
[TBL] [Abstract][Full Text] [Related]
12. A pharmacodynamic analysis of TCDD-induced cytochrome P450 gene expression in multiple tissues: dose- and time-dependent effects.
Santostefano MJ; Wang X; Richardson VM; Ross DG; DeVito MJ; Birnbaum LS
Toxicol Appl Pharmacol; 1998 Aug; 151(2):294-310. PubMed ID: 9707506
[TBL] [Abstract][Full Text] [Related]
13. Dose-response relationships in mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor, and protein tyrosine phosphorylation.
DeVito MJ; Ma X; Babish JG; Menache M; Birnbaum LS
Toxicol Appl Pharmacol; 1994 Jan; 124(1):82-90. PubMed ID: 8291065
[TBL] [Abstract][Full Text] [Related]
14. Biphasic response for hepatic microsomal enzyme induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice.
Shen ES; Guengerich FP; Olson JR
Biochem Pharmacol; 1989 Nov; 38(22):4075-84. PubMed ID: 2512931
[TBL] [Abstract][Full Text] [Related]
15. Interactive effects between 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,2',4,4',5,5'-hexachlorobiphenyl in female B6C3F1 mice: tissue distribution and tissue-specific enzyme induction.
van Birgelen AP; Ross DG; DeVito MJ; Birnbaum LS
Fundam Appl Toxicol; 1996 Nov; 34(1):118-31. PubMed ID: 8937899
[TBL] [Abstract][Full Text] [Related]
16. Disposition of 2,3,7,8-tetrabromodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat: biliary excretion and induction of cytochromes CYP1A1 and CYP1A2.
Kedderis LB; Diliberto JJ; Linko P; Goldstein JA; Birnbaum LS
Toxicol Appl Pharmacol; 1991 Oct; 111(1):163-72. PubMed ID: 1949032
[TBL] [Abstract][Full Text] [Related]
17. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
18. Tissue distribution after a single subcutaneous administration of 2,3,7,8-tetrabromodibenzo-p-dioxin in comparison with toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Wistar rats.
Nagao T; Yamashita K; Golor G; Bittmann H; Körner W; Hagenmaier H; Neubert D
Life Sci; 1996; 58(4):325-36. PubMed ID: 8538369
[TBL] [Abstract][Full Text] [Related]
19. The effect of dose on 2,3,7,8-TCDD tissue distribution, metabolism and elimination in CYP1A2 (-/-) knockout and C57BL/6N parental strains of mice.
Hakk H; Diliberto JJ; Birnbaum LS
Toxicol Appl Pharmacol; 2009 Nov; 241(1):119-26. PubMed ID: 19695277
[TBL] [Abstract][Full Text] [Related]
20. Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction.
Drahushuk AT; McGarrigle BP; Tai HL; Kitareewan S; Goldstein JA; Olson JR
Toxicol Appl Pharmacol; 1996 Oct; 140(2):393-403. PubMed ID: 8887457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
